113 related articles for article (PubMed ID: 3020248)
1. Cardiac glycosides. 7. Sugar stereochemistry and cardiac glycoside activity.
Rathore H; From AH; Ahmed K; Fullerton DS
J Med Chem; 1986 Oct; 29(10):1945-52. PubMed ID: 3020248
[TBL] [Abstract][Full Text] [Related]
2. Cardiac glycosides. 1. A systematic study of digitoxigenin D-glycosides.
Fullerton DS; Kihara M; Deffo T; Kitatsuji E; Ahmed K; Simat B; From AH; Rohrer DC
J Med Chem; 1984 Mar; 27(3):256-61. PubMed ID: 6321733
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and properties of digitoxigenin-3 beta-O-alpha-L-arabinofuranoside].
Schwabe K; Tschiersch B
Pharmazie; 1982 Dec; 37(12):827-8. PubMed ID: 6298840
[TBL] [Abstract][Full Text] [Related]
4. Cardiac glycosides. 6. Gitoxigenin C16 acetates, formates, methoxycarbonates, and digitoxosides. Synthesis and Na+,K+-ATPase inhibitory activities.
Hashimoto T; Rathore H; Satoh D; Hong G; Griffin JF; From AH; Ahmed K; Fullerton DS
J Med Chem; 1986 Jun; 29(6):997-1003. PubMed ID: 3012087
[TBL] [Abstract][Full Text] [Related]
5. Pregnanes that bind to the digitalis receptor: synthesis of 14-hydroxy-5 beta,14 beta-pregnane glycosides from digitoxin and digitoxigenin.
Templeton JF; Setiloane P; Kumar VP; Yan YL; Zeglam TH; LaBella FS
J Med Chem; 1991 Sep; 34(9):2778-82. PubMed ID: 1895297
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor.
Balzan S; D'Urso G; Ghione S; Martinelli A; Montali U
Life Sci; 2000 Sep; 67(16):1921-8. PubMed ID: 11072868
[TBL] [Abstract][Full Text] [Related]
7. Influence of extracellular K+ concentration on the time-course of Na+/K+-ATPase inhibition by cardiac glycosides with fast and low binding kinetics.
Gleitz J; Peters M
Eur J Pharmacol; 1997 Sep; 335(1):89-97. PubMed ID: 9371549
[TBL] [Abstract][Full Text] [Related]
8. Human cell mutants affected in the interaction of the 12 beta-OH group of cardiac glycosides with the digitalis receptor.
Gupta RS; Chopra A
Biochem Pharmacol; 1987 Nov; 36(22):3829-33. PubMed ID: 2825704
[TBL] [Abstract][Full Text] [Related]
9. Conformational factors in cardiac glycoside activity.
Chiu FC; Watson TR
J Med Chem; 1985 Apr; 28(4):509-15. PubMed ID: 3981544
[TBL] [Abstract][Full Text] [Related]
10. Influence of 16 beta formylation on Na, K-ATPase inhibition by cardiac glycosides.
De Pover A; Godfraind T
Naunyn Schmiedebergs Arch Pharmacol; 1982 Nov; 321(2):135-9. PubMed ID: 6296702
[TBL] [Abstract][Full Text] [Related]
11. Characterization, quantitation, similarity evaluation and combination with Na
Bai Y; Zhu W; Xu Y; Xie Z; Akihisa T; Manosroi J; Sun H; Feng F; Liu W; Zhang J
Bioorg Chem; 2019 Jun; 87():265-275. PubMed ID: 30908969
[TBL] [Abstract][Full Text] [Related]
12. The effect of 16 beta-substitution on the structure and activity of digitoxigenin: is there an additional binding interaction with Na+,K+-ATPase?
Griffin JF; Rohrer DC; Ahmed K; From AH; Hashimoto T; Rathore H; Fullerton DS
Mol Pharmacol; 1986 Mar; 29(3):270-4. PubMed ID: 3005835
[TBL] [Abstract][Full Text] [Related]
13. MTD approach to quantitative structure-activity relationships for cardiotonic steroids.
Bohl M; Simon Z
Z Naturforsch C Biosci; 1985; 40(11-12):858-62. PubMed ID: 3008458
[TBL] [Abstract][Full Text] [Related]
14. The lead structure in cardiac glycosides is 5 beta, 14 beta-androstane-3 beta 14-diol.
Schönfeld W; Weiland J; Lindig C; Masnyk M; Kabat MM; Kurek A; Wicha J; Repke KR
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):414-26. PubMed ID: 4033807
[TBL] [Abstract][Full Text] [Related]
15. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
Paula S; Tabet MR; Ball WJ
Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of cardiac steroids having a doubly linked sugar and related compounds for the inhibition of Na+,K+-adenosine triphosphatase.
Shimada K; Ishii N; Ohishi K; Ro JS; Nambara T
J Pharmacobiodyn; 1986 Sep; 9(9):755-9. PubMed ID: 3025406
[TBL] [Abstract][Full Text] [Related]
17. Comparative ability of digoxin and an aminosugar cardiac glycoside to bind to and inhibit Na+,K+-adenosine triphosphatase. Effect of potassium.
Songu-Mize E; Gunter JL; Caldwell RW
Biochem Pharmacol; 1989 Nov; 38(21):3689-95. PubMed ID: 2557026
[TBL] [Abstract][Full Text] [Related]
18. [The effect of the distribution of polar groups in a steroid molecule on its inhibition of Na+,K+-ATPase].
Kamernitskiĭ AV; Reshetova IG; Mirsalikhova NM; Uvarova NI; Atopkina LN
Bioorg Khim; 1984 May; 10(5):666-9. PubMed ID: 6093818
[TBL] [Abstract][Full Text] [Related]
19. Digitoxigenin 3-O-beta-D-furanosides.
Prisbe EJ; Verheyden JP; Montgomery WW; Strosberg AM
J Med Chem; 1986 Feb; 29(2):239-44. PubMed ID: 3950906
[TBL] [Abstract][Full Text] [Related]
20. Sugar moiety of cardiac glycosides is essential for the inhibitory action on the palytoxin-induced K+ release from red blood cells.
Ozaki H; Nagase H; Urakawa N
FEBS Lett; 1984 Jul; 173(1):196-8. PubMed ID: 6146536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
